Search

Mental health benefits of a pedometer-based exercise intervention for parents of children with cancer were identified.

Invasive fungal disease (IFD) remains a common and serious complication in children treated for leukaemia. Antifungal prescription in children with leukaemia presents unique challenges, particularly due to variation in IFD risk between and within leukaemia treatment protocols, drug toxicities and interactions between antifungals and chemotherapeutic agents.

Invasive fungal disease (IFD) occurs less frequently during treatment for solid compared to hematological malignancies in children, and risk groups are poorly defined. Retrospective national multicenter cohort data (2004-2013) were analyzed to document prevalence, clinical characteristics, and microbiology of IFD.

Invasive fungal disease (IFD) is a common and important complication in children with acute myeloid leukaemia (AML). We describe the epidemiology of IFD in a large multicentre cohort of children with AML.

Our case demonstrates that AML therapy, without HSCT, can be sufficient to treat this rare disease in children.

Brain tumors presenting in infancy, especially during the first 6 months of life.

Rare childhood cancers have not benefited to the same extent from the gains that have been made for their frequently occurring counterparts.

Invasive fungal infections are more common in children with high-risk acute lymphoblastic leukaemia and in relapsed disease

Recent research showed that precision medicine can identify new treatment strategies for patients with childhood cancers. However, it is unclear which patients will benefit most from precision-guided treatment.

With improvement in leukemia therapy, central nervous system (CNS) tumors are the leading cause of cancer mortality in children and the most expensive...